Protalix Biotherapeutics Inc (PLX) earnings · rev $52.7M
These earnings events as JSON? API free 100/dayProtalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
This PLX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PLX revenue for 2025-12-31 was $52.7M. Net income was -$6.6M. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. PLX currently screens at market cap $122.6M.
When the next PLX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 1.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PLX research stays on the stock page; the tape stays on the quote page.
PLX earnings FAQ
What are PLX's latest revenue and net income?
Latest cached Protalix Biotherapeutics Inc (PLX) revenue for Dec 31, 2025 was $52.7M. Net income was -$6.6M. Statements: https://lician.com/financials/plx
What is PLX's latest diluted EPS?
Latest cached Protalix Biotherapeutics Inc (PLX) diluted EPS for Dec 31, 2025 was -$0.08.
What period does the latest PLX earnings print cover?
The latest cached Protalix Biotherapeutics Inc (PLX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PLX revenue change from the prior cached period?
Cached Protalix Biotherapeutics Inc (PLX) revenue was down 1.2% from $53.4M (Dec 31, 2024) to $52.7M (Dec 31, 2025). Statements: https://lician.com/financials/plx
Where are PLX earnings listed?
Cached earnings facts for Protalix Biotherapeutics Inc (PLX) are listed at https://lician.com/earnings/plx. Statements: https://lician.com/financials/plx
Not investment advice.